CPS Technologies (CPSH) Q4 2024 earnings summary

Executive summary

• Q4 2024 revenue was $5.9 million, down from $6.7 million year-over-year due to the end of a major US Navy/HybridTech Armor® contract, but up 40% sequentially from Q3 as expanded production capacity and customer shipments increased.

• The company replaced lost contract revenue with new product sales, including its first commercial order for radiation shielding.

• Operating loss for Q4 was $1.3 million, compared to operating income of $0.1 million in the prior year.

• Management expects continued growth and improved profitability in 2025, driven by strong customer demand, new product lines, and a $13.3 million power module contract.

• Three new U.S. Army SBIR contracts were secured post-quarter, expanding externally funded programs to six.

Financial highlights

• Gross loss in Q4 was $0.3 million (gross margin -4.6%), compared to a gross profit of $1.1 million (17% margin) last year, impacted by non-recurring ramp-up and startup costs.

• SG&A expenses were $1.0 million, flat year-over-year, with some one-time costs related to the new audit firm.

• Cash and cash equivalents at year-end were $3.3 million, with $1 million in marketable securities, down from $8.8 million at the start of 2024.

• Trade receivables were $4.9 million and inventories $4.3 million at year-end.

• Repurchased 135,527 common shares by year-end 2024.

Outlook and guidance

• Management anticipates continued revenue growth and margin improvement in 2025 as production stabilizes and one-time ramp-up costs subside.

• Gross margin is targeted to return to 15%-20% as new employees gain experience and manufacturing yields improve.

• Externally funded research and new contracts are expected to expand the product portfolio into vehicles, aircraft, munitions, and industrial applications.

• Strong demand is anticipated for power module components, hermetic packaging, and new products such as radiation shielding.